<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome (XLP) is a rare, often fatal, primary <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> disease characterized by an abnormal response to Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The gene responsible for XLP has been identified as SH2D1A/DSHP/SLAM-associated protein (SAP) </plain></SENT>
<SENT sid="2" pm="."><plain>The major clinical manifestations include fulminant <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo>, and <z:hpo ids='HP_0002961'>dysgammaglobulinemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Affected males uncommonly present with lymphocytic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> in addition to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we describe a Japanese XLP patient who presented with <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> following <z:hpo ids='HP_0011009'>acute</z:hpo> EBV-induced <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> in the infancy and later had systemic lymphocytic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and <z:e sem="disease" ids="C0024291" disease_type="Disease or Syndrome" abbrv="">hemophagocytic lymphohistiocytosis</z:e> in the adulthood, which resolved by steroid pulse therapy </plain></SENT>
<SENT sid="5" pm="."><plain>The patient's SAP gene was found to harbor a missense mutation (His8Asp), presumably resulting in defective expression of SAP in T cells </plain></SENT>
<SENT sid="6" pm="."><plain>Biopsy specimens of lung and skin disclosed that CD8+ T cells predominantly infiltrated vascular vessels </plain></SENT>
<SENT sid="7" pm="."><plain>However, immunohistochemical examination showed that EBV-infected cells were not identifiable in the vessels </plain></SENT>
<SENT sid="8" pm="."><plain>We propose that T-cell-mediated <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> in XLP can cause <z:hpo ids='HP_0002633'>vasculitis</z:hpo> by <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e>-unrelated mechanism </plain></SENT>
</text></document>